2011•Xiandai shengwu yixue jinzhanRequires access

Doxofylline plus Asaroneon for Chronic Obstructive Pulmonary Disease

Yang Guo-hong

Open publisher page 0 citations

Abstract

Objective:To observe the efficacy of doxofylline and asarone on treatment of acute exacerbation of chronic obstructive pulmonary disease(AECOPD).Methods:A total of 164 patients with AECOPD were randomly divided into two groups(82 cases) and control group(82 cases).The control group were treated with the low-flow oxygen,anti-inflammatory,anti-infective,correct water and electrolyte disturbance such as combined therapy.On the basis of the control group,the observation group were added with injection asarone and doxofylline in vein.Symptoms,signs and blood gas analysis were observed before and after the treatment.Results:The total effective rate of the observation group and control group were 93.9%and 81.7%,respectively(P0.05).the duration of fever,cough, expectoration,wheezing and 50%reduction in pulmonary rales in the observation group were significantly shorter than that in the control group(P0.01).FEV1,FEV1/FVC,PEF,PaO_2,PaCO_2 and other indicators in the observation group were also significantly better than that in the control group(P0.01).Conclusion:On the basis of conventional therapy,asarone combined doxofylline can improve the clinical efficacy in patients with AECOPD.

About this research paper

What this paper is about

Objective:To observe the efficacy of doxofylline and asarone on treatment of acute exacerbation of chronic obstructive pulmonary disease(AECOPD).Methods:A total of 164 patients with AECOPD were randomly divided into two groups(82 cases) and control group(82 cases).The control group were treated with the low-flow oxygen,anti-inflammatory,anti-infective,correct water and electrolyte disturbance such as combined therapy.On the basis of the control group,the observation group were added with injection asarone and doxofylline in vein.Symptoms,signs and blood gas analysis were observed before and after the treatment.Results:The total effective rate of the observation group and control group were 93.9%and 81.7%,respectively(P0.05).the duration of fever,cough, expectoration,wheezing and 50%reduction in pulmonary rales in the observation group were significantly shorter than that in the control group(P0.01).FEV1,FEV1/FVC,PEF,PaO_2,PaCO_2 and other indicators in the observation group were also significantly better than that in the control group(P0.01).Conclusion:On the basis of conventional therapy,asarone combined doxofylline can improve the clinical efficacy in patients with AECOPD.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To observe the efficacy of doxofylline and asarone on treatment of acute exacerbation of chronic obstructive pulmonary disease(AECOPD).Methods:A total of 164 patients with AECOPD were randomly divided into two groups(82 cases) and control group(82 cases).The control group were treated with the low-flow oxygen,anti-inflammatory,anti-infective,correct water and electrolyte disturbance such as combined therapy.On the basis of the control group,the observation group were added with injection asarone and doxofylline in vein.Symptoms,signs and blood gas analysis were observed before and after the treatment.Results:The total effective rate of the observation group and control group were 93.9%and 81.7%,respectively(P0.05).the duration of fever,cough, expectoration,wheezing and 50%reduction in pulmonary rales in the observation group were significantly shorter than that in the control group(P0.01).FEV1,FEV1/FVC,PEF,PaO_2,PaCO_2 and other indicators in the observation group were also significantly better than that in the control group(P0.01).Conclusion:On the basis of conventional therapy,asarone combined doxofylline can improve the clinical efficacy in patients with AECOPD.

Key concepts: Medicine, Exacerbation, Pulmonary disease, Anesthesia, Internal medicine, COPD, Clinical efficacy, Treatment and control groups

Related papers

Back to paper searchBrowse research topicsOriginal source
Doxofylline plus Asaroneon for Chronic Obstructive Pulmonary Disease — Research Paper | ScholarLens